Cecchini G, Ferutta P, Soldà A, Ragazzi G
Minerva Ginecol. 1989 Jun;41(6):287-90.
The efficacy and tolerability of a new NSAID-flunoxaprofen-have been evaluated in patients suffering from non specific vaginitis, by topical application for 20 days (vaginal washings with water solution of the preparation). The activity of flunoxaprofen has been compared with that of benzidamine with regard to normalization of bacterial vaginal flora, taking into consideration the increase of Döderlein bacillus. A remarkable significant improvement of all the symptoms has been observed in the group of patients treated with flunoxaprofen with respect to that receiving benzidamine; moreover 57.9% of the subjects treated with flunoxaprofen showed a significant increase of Döderlein bacillus while in the benzidamine group the percentage reached a value of 11.8%. Flunoxaprofen may be considered a useful and active tool for the topical treatment of non specific vaginal diseases.
一种新型非甾体抗炎药——氟诺洛芬,通过局部应用20天(用该制剂的水溶液进行阴道冲洗),已在患有非特异性阴道炎的患者中评估了其疗效和耐受性。就阴道细菌菌群正常化而言,考虑到阴道乳酸杆菌的增加,已将氟诺洛芬的活性与苄达明的活性进行了比较。与接受苄达明治疗的患者组相比,在接受氟诺洛芬治疗的患者组中观察到所有症状均有显著明显改善;此外,接受氟诺洛芬治疗的受试者中有57.9%的人阴道乳酸杆菌显著增加,而在苄达明组中这一百分比为11.8%。氟诺洛芬可被认为是局部治疗非特异性阴道疾病的一种有用且有效的药物。